Atlas Trials

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

Clinical trial NCT00637663 · COMPLETED

Trial details

NCT number
NCT00637663
Sponsor
Pusan National University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2008-02-01
Primary completion
2010-11-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.